Continue reading "Kassenerstattung für Homöopathie vor dem Aus! Oder …?"
Homeopathy in Switzerland – breaking the ice?
Continue reading "Homeopathy in Switzerland – breaking the ice?"
Time for action! INH Open Letter on Homeopathy in the Health Sector
Continue reading "Time for action! INH Open Letter on Homeopathy in the Health Sector"
In the patient’s interest – An interview with Prof. Dr Lars Bräuer
Continue reading "In the patient’s interest – An interview with Prof. Dr Lars Bräuer"
Corona, Krankenkassen und Homöopathie – Nichts ist immer noch zu teuer!
Continue reading "Corona, Krankenkassen und Homöopathie – Nichts ist immer noch zu teuer!"
Neue Securvita-Studie in Sachen Homöopathie – spektakulär oder business as usual?
Continue reading "Neue Securvita-Studie in Sachen Homöopathie – spektakulär oder business as usual?"
“So okay” – no way, Minister Spahn! – A “Too long – Didn’t read” for those in a hurry.
“So okay”, Minister Spahn? – No way! – A guest article by health economist Prof. Dr. Tina Salomon
Open letter to Karin Maag, Member of the Bundestag – Reimbursement of Homeopathy
Continue reading "Open letter to Karin Maag, Member of the Bundestag – Reimbursement of Homeopathy"
Open letter of the INH to the German Federal Minister of Health on the “internal consensus” of the German medical law
Glasses, dentures and homeopathy – The role of German statutory health insurances
Continue reading "Glasses, dentures and homeopathy – The role of German statutory health insurances"
Alternative practitioners on pharmacy-only obligation and labelling of homeopathic remedies – a statement of the INH
Open letter of the INH to the Siemens health insurance company (SBK)
Continue reading "Open letter of the INH to the Siemens health insurance company (SBK)"
On homeopathy cost studies: Nothing is always too expensive
Continue reading "On homeopathy cost studies: Nothing is always too expensive"
Open letter of the information network homeopathy to the statutory health insurance “Die Techniker” (TK)
But health insurance companies wouldn’t pay for ineffective drugs!
Continue reading "But health insurance companies wouldn’t pay for ineffective drugs!"